MOHAMMED N AL HALLAK to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications MOHAMMED N AL HALLAK has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.119
-
The phase I/II eNRGy trial: Zenocutuzumab in?patients with cancers harboring NRG1 gene fusions. Future Oncol. 2024; 20(16):1057-1067.
Score: 0.046
-
Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer Metastasis Rev. 2021 06; 40(2):625-641.
Score: 0.038
-
Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020 12; 39(4):1179-1203.
Score: 0.036